Ameriprise’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.9M Buy
3,017,341
+426,357
+16% +$6.79M 0.01% 964
2025
Q4
$42.1M Sell
2,590,984
-3,380,722
-57% -$55.2M 0.01% 971
2025
Q3
$89.3M Buy
5,971,706
+2,731,648
+84% +$33.3M 0.02% 617
2025
Q2
$37.7M Sell
3,240,058
-3,402,418
-51% -$30.9M 0.01% 1007
2025
Q1
$49.4M Buy
6,642,476
+5,905,756
+802% +$45.4M 0.01% 845
2024
Q4
$4.42M Buy
736,720
+654,309
+794% +$3.61M ﹤0.01% 2444
2024
Q3
$422K Buy
82,411
+31,502
+62% +$137K ﹤0.01% 3543
2024
Q2
$184K Sell
50,909
-795,470
-94% -$2.52M ﹤0.01% 3703
2024
Q1
$2.72M Buy
846,379
+791,445
+1,441% +$3.06M ﹤0.01% 2716
2023
Q4
$269K Sell
54,934
-24,685
-31% -$113K ﹤0.01% 3640
2023
Q3
$434K Buy
79,619
+27,162
+52% +$180K ﹤0.01% 3459
2023
Q2
$352K Sell
52,457
-375,507
-88% -$2.79M ﹤0.01% 3567
2023
Q1
$3.78M Buy
427,964
+59,064
+16% +$521K ﹤0.01% 2505
2022
Q4
$2.82M Buy
+368,900
New +$2.87M ﹤0.01% 2646
2022
Q2
Sell
-648,479
Closed -$9M 3882
2022
Q1
$9M Buy
648,479
+68,205
+12% +$1.07M ﹤0.01% 1998
2021
Q4
$16.3M Sell
580,274
-226
-0% -$6.93K ﹤0.01% 1576
2021
Q3
$19.7M Buy
580,500
+47,418
+9% +$1.71M 0.01% 1275
2021
Q2
$21.8M Sell
533,082
-319,950
-38% -$12.4M 0.01% 1283
2021
Q1
$34.3M Buy
853,032
+97,490
+13% +$5.28M 0.01% 960
2020
Q4
$44.7M Buy
755,542
+164,134
+28% +$8.46M 0.02% 786
2020
Q3
$28.8M Buy
591,408
+246,292
+71% +$10.4M 0.01% 888
2020
Q2
$16.7M Buy
345,116
+12,445
+4% +$454K 0.01% 1167
2020
Q1
$9.24M Buy
332,671
+45,813
+16% +$1.28M ﹤0.01% 1447
2019
Q4
$8.58M Buy
286,858
+34,256
+14% +$984K ﹤0.01% 1866
2019
Q3
$7.81M Buy
252,602
+92,005
+57% +$3.75M ﹤0.01% 1887
2019
Q2
$7.76M Buy
+160,597
New +$7.11M ﹤0.01% 1918

Other funds holding ADPT